Catalyst Wire Dossier Catalyst Wire Dossier

Actemra RoActemra

tocilizumab · Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Actemra RoActemra, covering 2014-06-06 to 2014-06-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs [Phase 3]

See pricing